Publications

Publications

Filter Results: (13) Arrow Down

Show Results For

Page 1 of 13 Results
  • 2021
  • Working Paper

The Health Costs of Cost-Sharing

By: Amitabh Chandra, Evan Flack and Ziad Obermeyer
We use the design of Medicare’s prescription drug benefit program to demonstrate three facts about the health consequences of cost-sharing. First, we show that an as-if-random increase of 33.6% in out-of-pocket price (11.0 percentage points (p.p.) change in... View Details
Keywords: Cost-sharing; Impact; Health Care and Treatment; Insurance; Health; Consumer Behavior
Related
  • 15 Mar 2021
  • Working Paper Summaries

The Health Costs of Cost-Sharing

Keywords: by Amitabh Chandra, Evan Flack, and Ziad Obermeyer
  • January 2021
  • Case

Value-Based Insurance Design at Onex

By: Joshua Schwartzstein, Amitabh Chandra and Amram Migdal
The operating executives of Health and Benefits for Onex Partners, Megan Jackson Frye and Sam Camens, faced a challenge: Healthcare costs for employees of Onex’s portfolio companies were continuing to rise above the consumer price index, reflecting broader trends... View Details
Keywords: Decision Making; Cost vs Benefits; Decision Choices and Conditions; Decisions; Finance; Behavioral Finance; Insurance; Health; Health Care and Treatment; Human Resources; Compensation and Benefits; Markets; Demand and Consumers; Consumer Behavior; Social Psychology; Behavior; Interests; Motivation and Incentives; Perception; Health Industry; Insurance Industry; North America; United States
Related
  • January 1995 (Revised March 1997)
  • Case

A Bankruptcy Problem from the Talmud

Describes a problem of bankruptcy, following the treatment in the 2,000-year-old Babylonian Talmud. A person dies, leaving a number of debts that total more than the size of the estate. The question is: How should the estate be divided among the creditors? The case... View Details
Keywords: Analysis; Insolvency and Bankruptcy; Economics
Related
  • 2019
  • Chapter

Behavioral Economics and Health-Care Markets

By: Amitabh Chandra, Benjamin Handel and Joshua Schwartzstein
This chapter summarizes research in behavioral health economics, focusing on insurance markets and product markets in health care. We argue that the prevalence of choice difficulties and biases leading to mistakes in these markets establish a special place for them in... View Details
Keywords: Behavioral Economics; Consumer Behavior; Economics; Health Care and Treatment; Insurance; Markets
Related
  • August 2024
  • Article

How Do Copayment Coupons Affect Branded Drug Prices and Quantities Purchased?

By: Leemore S. Dafny, Kate Ho and Edward Kong
Drug copayment coupons to reduce patient cost-sharing have become nearly ubiquitous for high-priced brand-name prescription drugs. Medicare bans such coupons on the grounds that they are kickbacks that induce utilization, but they are commonly used by... View Details
Keywords: Prescription Drugs; Coupons; Impact; Health Care and Treatment; Markets; Price; Spending; Pharmaceutical Industry; United States
Related

    How Do Drug Copayment Coupons Affect Branded Drug Prices and Quantities Purchased?

    Drug copayment coupons to reduce patient cost-sharing have become nearly ubiquitous for high-priced brand-name prescription drugs. Medicare bans such coupons on the grounds that they are kickbacks that induce utilization, but they are commonly used by... View Details
    • Web

    Health Care - Faculty & Research

    Best Paper Proceedings 2024, no. 1 (2024). How Do Copayment Coupons Affect Branded Drug Prices and Quantities Purchased? By: Leemore S. Dafny , Kate Ho and Edward Kong August 2024 | Article | American Economic Journal: Economic Policy Drug copayment coupons to reduce... View Details
    • Web

    Research - Health Care

    Do Copayment Coupons Affect Branded Drug Prices and Quantities Purchased? By: Leemore S. Dafny , Kate Ho and Edward Kong Drug copayment coupons to reduce patient cost-sharing have become nearly ubiquitous for high-priced brand-name... View Details
    • 31 Mar 2023
    • Research & Ideas

    Can a ‘Basic Bundle’ of Health Insurance Cure Coverage Gaps and Spur Innovation?

    will increase incentives for innovators to invest in new treatments,” the researchers say. A basic bundle would also need cost-sharing rules, provider payments, and myriad other details. Often, these are decisions that require detailed... View Details
    Keywords: by Kasandra Brabaw; Insurance; Health
    • 06 Sep 2022
    • Research & Ideas

    Curbing an Unlikely Culprit of Rising Drug Prices: Pharmaceutical Donations

    encouraging the use of expensive drugs over cheaper alternatives.” Drugmakers can provide direct aid to privately insured patients—and they do. For example, many drugmakers issue “copay coupons” that cover cost-sharing for their drugs.... View Details
    Keywords: by Ben Rand; Insurance; Health; Pharmaceutical
    • 03 Sep 2020
    • Op-Ed

    Why American Health Care Needs Its Own SEC

    in-network and out-of-network providers, and disclose consumers’ cost-sharing liability. Hospitals and insurers lost their lawsuit to block these rules from coming into effect, but say they will appeal. Their lobbying clout is powerful... View Details
    Keywords: by Regina E. Herzlinger; Health
    • 19 Feb 2019
    • First Look

    New Research and Ideas, February 19, 2019

    deductibles. We show how choice difficulties or biases may lead patients to respond to such increases in patient cost-sharing by reducing demand for high-value care, muddying the traditional argument that the price elasticity of demand... View Details
    Keywords: Sean Silverthorne